Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
At the Federal Trade Commission, Chair Lina Khan's mission is breaking illegal monopolies, blocking mergers that stifle ...
Axios Sneak Peek on MSN38m
Kroger-Albertsons merger could increase grocery costs, FTC chair saysFederal Trade Commission Chair Lina Khan suggested in an interview broadcast Sunday that the largest-ever proposed grocery ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
In an interview with 60 Minutes, the Federal Trade Commission head said the agency believes it has the authority to ban ...
It’s been almost a month since the new FTC rule was officially approved, but if you still can’t smell what The Rock-a-Khan is ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback